|Last Price$27.19||Day Change (%)0.37%|
|Open Price$27.10||Day Change ($)0.10|
|Day Range27.09–27.19||52-Week Range25.50–29.13|
As of Fri 10/21/2016 5:02:00 PM | USD
Global Medical Tubing Market Growth at CAGR of 8%, 2016-2021: Saint-Gobain, Freudenberg Medical, W.L.Gore Associates & Vention Medical Dominate the $5.8 Billion Market - Research and Markets
Global $14.88 Billion Automotive Refinish Coatings Market Analysis By Resin Type, By Technology, By Product, By Vehicle Age And Segment Forecasts To 2024 - Research and Markets
Palisades Hudson Newsletter: http://palisadeshudson.com/sentinel/ Larry Elkin's Blog: http://palisadeshudson.com/current-commentary/
Sokol's resignation clouds Berkshire's succession plan, while his Lubrizol trades tarnish to some extent the firm's legacy of strong ethical behavior.
Quarterly results were an improvement on prior-year earnings, though book value per share came in lower than we expected.
Berkshire's non-insurance operations continue to be an added source of stability while reinsurance operations continue to struggle.
Wide-moat Berkshire Hathaway saw solid top-line results from each of its main segments, but losses from investments, derivatives, and eliminations sent earnings lower.
2013 results once again demonstrate the value of Berkshire's diversified portfolio, as solid and consistent performance from the firm's non-insurance operations helped smooth out some of the volatility seen in its insurance businesses.
Alternative methods have some use, but we think discounted cash flow is the most fundamentally sound way to value the conglomerate, as we discuss in the final installment of our 5-part series.
Morningstar's Gregg Warren, who will be on the analyst panel at this year's meeting, details the questions he hopes Buffett and Munger will address.